Overview
Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
Status:
Completed
Completed
Trial end date:
2009-10-01
2009-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana responsible for its reinforcing effects, may decrease marijuana cravings. The purpose of this study is to evaluate the effect of THC pre-treatment on responses to marijuana-related cues versus non marijuana-related cues in individuals addicted to marijuana.Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Wayne State UniversityCollaborator:
National Institute on Drug Abuse (NIDA)Treatments:
Dronabinol
Criteria
Inclusion Criteria:- Meets DSM-IV diagnosis criteria for marijuana dependence
- Able to read and write in English
- Positive urine test for marijuana
- If female, must be willing to use contraception throughout the study
Exclusion Criteria:
- Meets DSM-IV diagnosis criteria for a psychiatric illness
- History of a psychotic disorder
- Seeking treatment for marijuana dependence
- Neurologic disease, including structural brain abnormalities (e.g., neoplasms),
stroke, seizures, infectious disease, head trauma resulting in unconsciousness, or
evidence of neurologic illness resulting from HIV/AIDS
- Cardiovascular disease, including edema, chest pain or palpitations after exertion or
drug use, myocardial infarction (heart attack), systolic blood pressure greater than
160 mm Hg or less than 95 mm Hg, or diastolic blood pressure greater than 95 mm Hg
- Pulmonary disease, including apnea, cor pulmonale, tuberculosis, dyspnea, orthopnea,
or tachypnea
- Systemic disease, including endocrinopathies, kidney or liver failure, hypothyroidism,
adrenocortical insufficiency, or autoimmune disease involving the central nervous
system
- Currently dependent on any drug other than marijuana or nicotine
- Cognitively impaired
- Pregnant or breastfeeding